Coronavirus Vaccine / Rare nerve disorder from Johnson & Johnson's corona vaccine, EU also admitted side effects

Zoom News : Jul 23, 2021, 04:10 PM
Between Corona Vaccination, Johnson and Johnson have got big news. European Union has listed a new side effects of Johnson and Johnson Vaccine (Johnson and Johnson Corona Vaccine). EU has listed a rare and potentially hazardous neurological disease (Rair Nevan Disorder) as a side effect of Johnson and Johnson's corona vaccine.

Earlier, last week, the US Regulatory Institute Food and Drug Administration (FDA) had issued a new warning to Johnson and Johnson's Corona Vaccine (Janssen Vaccine) connected to the risk of rare and potentially dangerous nerve disease. Although the FDA had said that it is not completely clear whether J & J vaccine creates such problems or not.

According to News Agency Reuters, now the medical regulator of Europe has listed a rare and potentially dangerous neurological disease (Rare Neo Disorder). This side effect identified by Guillain-Barré Syndrome is likely to be considered connected to Johnson and Johnson vaccine. The Medical Regulator of EU has taken it after the study of 108 cases around the world.

The European Medicine Agency said, 'After the data received, the Prac has believed that Korean Vacc is some relationship in Janssen and GBS.' Pharmacobigrence Risk Assessment Committee (PRAC), European Medicine Agency's Safety Committee.


What is Gillen-Barre Syndrome

Gillen-Barre Syndrome can also cause weakness in muscle and sometimes falges. When the FDA and the Disease Control and Prevention Center (CDC) reviewed reports to flourish the disease in about 100 people who have taken the first dose of J & J vaccine. Of these, almost all needed to be admitted to the hospital and a person died.

According to the CDC, the Gillen-Burre Syndrome occurs, the body's resistance system is mistakenly attacked its own nerve cells, which causes muscle weakness and sometimes the condition of the folic, which is usually temporarily temporarily. Every year there is a disease in about 3,000 to 6,000 people.

SUBSCRIBE TO OUR NEWSLETTER